Vasamed Inc logo

VSMD - Vasamed Inc Share Price

$0.011 0.0  0.0%

Last Trade - 01/10/20

Sector
Healthcare
Size
Micro Cap
Market Cap £65.1k
Enterprise Value £1.40m
Revenue £2.63m
Position in Universe th / 6447
Bullish
Bearish
Unlock VSMD Revenue
Momentum
Relative Strength (%)
1m -51.1%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2003 2004 2005 2006 2007 2008 2009E 2010E CAGR / Avg
2.13 1.07 1.39 2.00 3.13 3.14 +8.1%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2009, Vasamed, Inc. revenues increased 22% to $1.7M. Net loss decreased 52% to $933K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Research/Development decrease of 26% to $587K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.24 to -$0.12.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

VSMD Revenue Unlock VSMD Revenue

Net Income

VSMD Net Income Unlock VSMD Revenue

Normalised EPS

VSMD Normalised EPS Unlock VSMD Revenue

PE Ratio Range

VSMD PE Ratio Range Unlock VSMD Revenue

Dividend Yield Range

VSMD Dividend Yield Range Unlock VSMD Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
VSMD EPS Forecasts Unlock VSMD Revenue
Profile Summary

Vasamed Incorporated designs, licenses, manufactures and distributes products, software and services for assessing and managing hemodynamic health. Its SensiLase peripheral arterial disease (PAD)-IQ Studycast System provides measurement of tissue perfusion of the extremities particularly in patients with combined peripheral arterial disease and diabetes. The SensiLase PAD-IQ Studycast supports non-invasive upper and lower extremity vascular assessments, including skin perfusion pressure microcirculation pulse volume recording and ankle brachial index (ABI) calculation for doppler-obtained pressures; data sorting and customization options to support database mining, and wound imaging and surface area calculation featuring SmartDraw. SensiLase PAD-IQ System featuring Studycast Data Management offers health professionals various support tools for both PAD and critical limb ischemia. Its AcQtrac System technology is designed to measure cardiac and hemodynamic parameters.

Directors
Last Annual December 31st, 2008
Last Interim June 30th, 2009
Incorporated December 7, 1995
Public Since February 14, 1996
No. of Shareholders: n/a
No. of Employees: 31
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 8,011,457
Free Float (0.0%)
Eligible for
ISAs
SIPPs
VSMD Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for VSMD
Upcoming Events for VSMD
Frequently Asked Questions for Vasamed Inc
What is the Vasamed Inc share price?

As of 01/10/20, shares in Vasamed Inc are trading at $0.011, giving the company a market capitalisation of £65.1k. This share price information is delayed by 15 minutes.

How has the Vasamed Inc share price performed this year?

Shares in Vasamed Inc are currently trading at $0.011 and the price has moved by 32.5% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Vasamed Inc price has moved by 22.15% over the past year.

What are the analyst and broker recommendations for Vasamed Inc?

There are no analysts currently covering Vasamed Inc.

When will Vasamed Inc next release its financial results?

Vasamed Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2010-06-30
What is the Vasamed Inc dividend yield?

Vasamed Inc does not currently pay a dividend.

Does Vasamed Inc pay a dividend?

Vasamed Inc does not currently pay a dividend.

When does Vasamed Inc next pay dividends?

Vasamed Inc does not currently pay a dividend.

How do I buy Vasamed Inc shares?

To buy shares in Vasamed Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Vasamed Inc?

Shares in Vasamed Inc are currently trading at $0.011, giving the company a market capitalisation of £65.1k.

Where are Vasamed Inc shares listed? Where are Vasamed Inc shares listed?

Here are the trading details for Vasamed Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: VSMD
What kind of share is Vasamed Inc?

We were not able to load our ranking data for Vasamed Inc

Is there a Vasamed Inc share price forecast 2020?

We were not able to load any forecast data for Vasamed Inc.

How can I tell whether the Vasamed Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vasamed Inc. Over the past six months, the relative strength of its shares against the market has been -33.23%. At the current price of $0.011, shares in Vasamed Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Vasamed Inc PE Ratio?

We were not able to find PE ratio data for Vasamed Inc.

Who are the key directors of Vasamed Inc?

Vasamed Inc's management team is headed by:

Paulita LaPlante - PRE
Roberta Dircks - CFO
Andrew Jay - DRC
Richard Egen - DRC
Terry Duesterhoeft - VPR
Kent Winger - VOP
Craig Walker - DRC
Charles Snead - DRC
Who are the major shareholders of Vasamed Inc?

Here are the top five shareholders of Vasamed Inc based on the size of their shareholding:

Bartlett & Company Investment Advisor
Percentage owned: 0.34% (27.5k shares)
Similar to VSMD
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.